Literature DB >> 28948667

Categorical and dimensional perspectives on depression in elderly primary care patients - Results of the AgeMooDe study.

Marie Dorow1, Janine Stein1, Alexander Pabst1, Siegfried Weyerer2, Jochen Werle2, Wolfgang Maier3, Lisa Miebach3, Martin Scherer4, Anne Stark4, Birgitt Wiese5, Lilia Moor5, Jens-Oliver Bock6, Hans-Helmut König6, Steffi G Riedel-Heller1.   

Abstract

An accurate diagnosis is essential for the management of late-life depression in primary care. This study aims to (1) provide information on the agreement on depression diagnoses between general practitioners (GPs), dimensional tools (Geriatric Depression Scale [GDS], Hospital Anxiety and Depression Scale [HADS]) and a categorical tool (Structured Clinical Interview for DSM-IV criteria [SCID]) and (2) identify factors associated with different diagnoses. As part of the multicenter study "Late-life depression in primary care: needs, health care utilization and costs (AgeMooDe)" a sample of 1113 primary care patients aged 75 years and older was assessed. The proportion of depression was 24.3% according to GPs, 21.8% for the GDS, 18.9% for the HADS and 8.2% for the SCID. Taking GDS, HADS and SCID as reference standards, recognition of GPs was 47%, 48% and 63%. Cohen's Kappa values indicate slight to moderate agreement between diagnoses. Multinomial logistic regression models showed that patient related factors of depression were anxiety, intake of antidepressants, female gender, a low state of health, intake of medication for chronic diseases and functional impairment. GPs performed better at ruling out depression than ruling in depression. High levels of disagreement between different perspectives on depression indicate that they may be sensitive to different aspects of depression.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Keywords:  depression diagnosis primary care; old age; risk factors

Mesh:

Year:  2017        PMID: 28948667      PMCID: PMC6877261          DOI: 10.1002/mpr.1577

Source DB:  PubMed          Journal:  Int J Methods Psychiatr Res        ISSN: 1049-8931            Impact factor:   4.035


  52 in total

Review 1.  Health service utilization and costs of depressive symptoms in late life - a systematic review.

Authors:  Melanie Luppa; Claudia Sikorski; Tom Motzek; Alexander Konnopka; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Understanding primary care physicians' propensity to assess elderly patients for depression using interaction and survey data.

Authors:  Ming Tai-Seale; Rachel Bramson; David Drukker; Margo-Lea Hurwicz; Marcia Ory; Thomas Tai-Seale; Richard Street; Mary Ann Cook
Journal:  Med Care       Date:  2005-12       Impact factor: 2.983

3.  Do GPs' medical records demonstrate a good recognition of depression? A new perspective on case extraction.

Authors:  Karlijn J Joling; Harm W J van Marwijk; Ellen Piek; Henriëtte E van der Horst; Brenda W Penninx; Peter Verhaak; Hein P J van Hout
Journal:  J Affect Disord       Date:  2011-05-24       Impact factor: 4.839

4.  Psychiatric caseness is a marker of major depressive episode in general practice.

Authors:  Søren Dinesen Ostergaard; Leslie Foldager; Christer Allgulander; Alv A Dahl; Marja-Terttu Huuhtanen; Ib Rasmussen; Povl Munk-Jørgensen
Journal:  Scand J Prim Health Care       Date:  2010-07-13       Impact factor: 2.581

5.  Primary care physician office visits for depression by older Americans.

Authors:  Jeffrey S Harman; Peter J Veazie; Jeffrey M Lyness
Journal:  J Gen Intern Med       Date:  2006-09       Impact factor: 5.128

Review 6.  The diagnostic accuracy of brief versions of the Geriatric Depression Scale: a systematic review and meta-analysis.

Authors:  Claire Pocklington; Simon Gilbody; Laura Manea; Dean McMillan
Journal:  Int J Geriatr Psychiatry       Date:  2016-02-18       Impact factor: 3.485

7.  Depression in relation to age and gender in the general population: the Nord-Trøndelag Health Study (HUNT).

Authors:  E Stordal; M Bjartveit Krüger; N H Dahl; Ø Krüger ; A Mykletun; A A Dahl
Journal:  Acta Psychiatr Scand       Date:  2001-09       Impact factor: 6.392

8.  [Barriers and Opportunities for Optimized Treatment of Late Life Depression].

Authors:  Uta Gühne; Melanie Luppa; Janine Stein; Birgitt Wiese; Siegfried Weyerer; Wolfgang Maier; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  Psychiatr Prax       Date:  2015-07-09

9.  Association between depression and socio-economic status among community-dwelling elderly in Japan: the Aichi Gerontological Evaluation Study (AGES).

Authors:  Chiyoe Murata; Katsunori Kondo; Hiroshi Hirai; Yukinobu Ichida; Toshiyuki Ojima
Journal:  Health Place       Date:  2007-09-01       Impact factor: 4.078

10.  Depression symptomatology and diagnosis: discordance between patients and physicians in primary care settings.

Authors:  Chizobam Ani; Mohsen Bazargan; David Hindman; Douglas Bell; Muhammad A Farooq; Lutful Akhanjee; Francis Yemofio; Richard Baker; Michael Rodriguez
Journal:  BMC Fam Pract       Date:  2008-01-03       Impact factor: 2.497

View more
  2 in total

1.  Categorical and dimensional perspectives on depression in elderly primary care patients - Results of the AgeMooDe study.

Authors:  Marie Dorow; Janine Stein; Alexander Pabst; Siegfried Weyerer; Jochen Werle; Wolfgang Maier; Lisa Miebach; Martin Scherer; Anne Stark; Birgitt Wiese; Lilia Moor; Jens-Oliver Bock; Hans-Helmut König; Steffi G Riedel-Heller
Journal:  Int J Methods Psychiatr Res       Date:  2017-09-25       Impact factor: 4.035

2.  Superoxide imbalance triggered by Val16Ala-SOD2 polymorphism increases the risk of depression and self-reported psychological stress in free-living elderly people.

Authors:  Ivo Emilio da Cruz Jung; Ivana Beatrice Mânica da Cruz; Fernanda Barbisan; Alexis Trott; Lucien J Houenou; Bárbara Osmarin Turra; Thiago Duarte; Raquel de Souza Praia; Ednea Aguiar Maia-Ribeiro; Jaqueline da Costa Escobar Piccoli; Claudia Giugliano Bica; Marta Maria Medeiros Frescura Duarte
Journal:  Mol Genet Genomic Med       Date:  2019-12-31       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.